Fagot-Campagna A, Pettitt DJ, Engelgau MM: Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. The Journal of Pediatrics. 2000, 136 (5): 664-672. 10.1067/mpd.2000.105141.
CAS
PubMed
Google Scholar
Poirier P, Giles TD, Bray GA: Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arteriosclerosis, Thrombosis, and Vascular Biology. 2006, 26 (5): 968-976. 10.1161/01.ATV.0000216787.85457.f3.
CAS
PubMed
Google Scholar
Clark JM: The epidemiology of nonalcoholic fatty liver disease in adults. Journal of Clinical Gastroenterology. 2006, 40 (supplement 1): S5-S10.
PubMed
Google Scholar
Puhl RM, Latner JD: Stigma, obesity, and the health of the nation's children. Psychological Bulletin. 2007, 133 (4): 557-580. 10.1037/0033-2909.133.4.557.
PubMed
Google Scholar
Serdula MK, Ivery D, Coates RJ, Freedman DS, Williamson DF, Byers T: Do obese children become obese adults? A review of the literature. Preventive Medicine. 1993, 22 (2): 167-177. 10.1006/pmed.1993.1014.
CAS
PubMed
Google Scholar
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999–2004. The Journal of the American Medical Association. 2006, 295 (13): 1549-1555. 10.1001/jama.295.13.1549.
CAS
PubMed
Google Scholar
Wang Y, Lobstein T: Worldwide trends in childhood overweight and obesity. International Journal of Pediatric Obesity. 2006, 1 (1): 11-25. 10.1080/17477160600586747.
PubMed
Google Scholar
Ogden CL, Yanovski SZ, Carroll MD, Flegal KM: The epidemiology of obesity. Gastroenterology. 2007, 132 (6): 2087-2102. 10.1053/j.gastro.2007.03.052.
PubMed
Google Scholar
Troiano RP, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL: Overweight prevalence and trends for children and adolescents. The National Health and Nutrition Examination Surveys, 1963 to 1991. Archives of Pediatrics and Adolescent Medicine. 1995, 149 (10): 1085-1091. 10.1001/archpedi.1995.02170230039005.
CAS
PubMed
Google Scholar
Strauss RS, Pollack HA: Epidemic increase in childhood overweight, 1986–1998. The Journal of the American Medical Association. 2001, 286 (22): 2845-2848. 10.1001/jama.286.22.2845.
CAS
PubMed
Google Scholar
Springer J, von Haehling S, Anker SD: The need for a standardized definition for cachexia in chronic illness. Nature Clinical Practice Endocrinology & Metabolism. 2006, 2 (8): 416-417. 10.1038/ncpendmet0247.
Google Scholar
Hallioglu O, Alehan D, Kandemir N: Plasma leptin levels in children with cyanotic and acyanotic congenital heart disease and correlations with growth parameters. International Journal of Cardiology. 2003, 92 (1): 93-97. 10.1016/S0167-5273(03)00044-5.
PubMed
Google Scholar
Burnham JM, Shults J, Semeao E: Body-composition alterations consistent with cachexia in children and young adults with Crohn disease. American Journal of Clinical Nutrition. 2005, 82 (2): 413-420.
CAS
PubMed
Google Scholar
Mak RH, Cheung W, Cone RD, Marks D: Mechanisms of disease: cytokine and adipokine signaling in uremic cachexia. Nature Clinical Practice Nephrology. 2006, 2 (9): 527-534. 10.1038/ncpneph0273.
CAS
PubMed
Google Scholar
Mak RH, Cheung W: Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling. Hormones, autacoids, neurotransmitters and growth factors. Current Opinion in Nephrology & Hypertension. 2007, 16 (1): 27-31. 10.1097/MNH.0b013e3280117ce7.
CAS
Google Scholar
Lai J-S, Cella D, Peterman A, Barocas J, Goldman S: Anorexia/cachexia-related quality of life for children with cancer: testing the psychometric properties of the pediatric functional assessment of anorexia and cachexia therapy (peds-FAACT). Cancer. 2005, 104 (7): 1531-1539. 10.1002/cncr.21315.
PubMed
Google Scholar
Baracos VE: Cancer-associated cachexia and underlying biological mechanisms. Annual Review of Nutrition. 2006, 26 (1): 435-461. 10.1146/annurev.nutr.26.061505.111151.
CAS
PubMed
Google Scholar
Morley JE, Thomas DR, Wilson M-MG: Cachexia: pathophysiology and clinical relevance. American Journal of Clinical Nutrition. 2006, 83 (4): 735-743.
CAS
PubMed
Google Scholar
Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF: Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides. 1986, 7 (6): 1189-1192. 10.1016/0196-9781(86)90149-X.
CAS
PubMed
Google Scholar
Leibel RL, Chung WK, Chua SC: The molecular genetics of rodent single gene obesities. The Journal of Biological Chemistry. 1997, 272 (51): 31937-31940. 10.1074/jbc.272.51.31937.
CAS
PubMed
Google Scholar
Ollmann MM, Lamoreux ML, Wilson BD, Barsh GS: Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo. Genes & Development. 1998, 12 (3): 316-330. 10.1101/gad.12.3.316.
CAS
Google Scholar
Yang Y-K, Thompson DA, Dickinson CJ: Characterization of Agouti-related protein binding to melanocortin receptors. Molecular Endocrinology. 1999, 13 (1): 148-155. 10.1210/me.13.1.148.
CAS
PubMed
Google Scholar
Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS: A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001, 50 (8): 1714-1719. 10.2337/diabetes.50.8.1714.
CAS
PubMed
Google Scholar
van der Lely AJ, Tschöp M, Heiman ML, Ghigo E: Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocrine Reviews. 2004, 25 (3): 426-457. 10.1210/er.2002-0029.
CAS
PubMed
Google Scholar
Wren AM, Small CJ, Abbott CR: Ghrelin causes hyperphagia and obesity in rats. Diabetes. 2001, 50 (11): 2540-2547. 10.2337/diabetes.50.11.2540.
CAS
PubMed
Google Scholar
Druce MR, Wren AM, Park AJ: Ghrelin increases food intake in obese as well as lean subjects. International Journal of Obesity. 2005, 29 (9): 1130-1136. 10.1038/sj.ijo.0803001.
CAS
PubMed
Google Scholar
Greenman Y, Golani N, Gilad S, Yaron M, Limor R, Stern N: Ghrelin secretion is modulated in a nutrient- and gender-specific manner. Clinical Endocrinology. 2004, 60 (3): 382-388. 10.1111/j.1365-2265.2004.01993.x.
PubMed
Google Scholar
Choi K, Roh S-G, Hong Y-H: The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology. 2003, 144 (3): 754-759. 10.1210/en.2002-220783.
CAS
PubMed
Google Scholar
Matsumura K, Tsuchihashi T, Fujii K, Abe I, Iida M: Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension. 2002, 40 (5): 694-699. 10.1161/01.HYP.0000035395.51441.10.
CAS
PubMed
Google Scholar
Thompson NM, Gill DAS, Davies R: Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology. 2004, 145 (1): 234-242. 10.1210/en.2003-0899.
CAS
PubMed
Google Scholar
Tschop M, Smiley DL, Heiman ML: Ghrelin induces adiposity in rodents. Nature. 2000, 407 (6806): 908-913. 10.1038/35038090.
CAS
PubMed
Google Scholar
Nagaya N, Uematsu M, Kojima M: Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation. 2001, 104 (17): 2034-2038. 10.1161/hc4201.097836.
CAS
PubMed
Google Scholar
Otto B, Cuntz U, Fruehauf E: Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. European Journal of Endocrinology. 2001, 145 (5): 669-673.
CAS
PubMed
Google Scholar
Shiiya T, Nakazato M, Mizuta M: Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. The Journal of Clinical Endocrinology & Metabolism. 2002, 87 (1): 240-244. 10.1210/jc.87.1.240.
CAS
Google Scholar
Shimizu Y, Nagaya N, Isobe T: Increased plasma ghrelin level in lung cancer cachexia. Clinical Cancer Research. 2003, 9 (2): 774-778.
CAS
PubMed
Google Scholar
Tolle V, Kadem M, Bluet-Pajot M-T: Balance in Ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. The Journal of Clinical Endocrinology & Metabolism. 2003, 88 (1): 109-116. 10.1210/jc.2002-020645.
CAS
Google Scholar
Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML: Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001, 50 (4): 707-709. 10.2337/diabetes.50.4.707.
PubMed
Google Scholar
Cummings DE, Clement K, Purnell JQ: Elevated plasma ghrelin levels in Prader-Willi syndrome. Nature Medicine. 2002, 8 (7): 643-644. 10.1038/nm0702-643.
CAS
PubMed
Google Scholar
DeBoer MD, Zhu X, Levasseur PR: Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology. 2008, 149 (2): 827-835. 10.1210/en.2007-1046.
PubMed Central
CAS
PubMed
Google Scholar
DeBoer MD, Xin XZ, Levasseur P: Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology. 2007, 148 (6): 3004-3012. 10.1210/en.2007-0016.
CAS
PubMed
Google Scholar
Huszar D, Lynch CA, Fairchild-Huntress V: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997, 88 (1): 131-141. 10.1016/S0092-8674(00)81865-6.
CAS
PubMed
Google Scholar
Farooqi IS, Keogh JM, Yeo GSH, Lank EJ, Cheetham T, O'Rahilly S: Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. The New England Journal of Medicine. 2003, 348 (12): 1085-1095. 10.1056/NEJMoa022050.
CAS
PubMed
Google Scholar
Krude H, Biebermann H, Schnabel D: Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. The Journal of Clinical Endocrinology & Metabolism. 2003, 88 (10): 4633-4640. 10.1210/jc.2003-030502.
CAS
Google Scholar
DeBoer MD, Marks D: Therapy insight: use of melanocortin antagonists in the treatment of cachexia in chronic disease. Nature Clinical Practice Endocrinology & Metabolism. 2006, 2 (8): 459-466. 10.1038/ncpendmet0221.
CAS
Google Scholar
Foster AC, Chen C, Markison S, Marks D: MC4 receptor antagonists: a potential treatment for cachexia. IDrugs. 2005, 8 (4): 314-319.
CAS
PubMed
Google Scholar
Menyhért J, Wittmann G, Lechan RM, Keller É, Liposits Z, Fekete C: Cocaine- and amphetamine-regulated transcript (CART) is colocalized with the orexigenic neuropeptide Y and agouti-related protein and absent from the anorexigenic
-melanocyte-stimulating hormone neurons in the infundibular nucleus of the human hypothalamus. Endocrinology. 2007, 148 (9): 4276-4281. 10.1210/en.2007-0390.
PubMed
Google Scholar
Kristensen P, Judge ME, Thim L: Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature. 1998, 393 (6680): 72-76. 10.1038/29993.
CAS
PubMed
Google Scholar
Koylu EO, Couceyro PR, Lambert PD, Kuhar MJ: Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain. The Journal of Comparative Neurology. 1998, 391 (1): 115-132. 10.1002/(SICI)1096-9861(19980202)391:1<115::AID-CNE10>3.0.CO;2-X.
CAS
PubMed
Google Scholar
Stanley SA, Small CJ, Murphy KG: Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats. Brain Research. 2001, 893 (1-2): 186-194. 10.1016/S0006-8993(00)03312-6.
CAS
PubMed
Google Scholar
Lambert PD, Couceyro PR, Mcgirr KM, Dall Vechia SE, Smith Y, Kuhar MJ: CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse. 1998, 29 (4): 293-298. 10.1002/(SICI)1098-2396(199808)29:4<293::AID-SYN1>3.0.CO;2-0.
CAS
PubMed
Google Scholar
Ivy AC, Oldberg E: A hormone mechanism for gall-bladder contraction and evacuation. The American Journal of Physiology. 1928, 86 (3): 599-613.
CAS
Google Scholar
Gibbs J, Young RC, Smith GP: Cholecystokinin decreases food intake in rats. Journal of Comparative and Physiological Psychology. 1973, 84 (3): 488-495. 10.1037/h0034870.
CAS
PubMed
Google Scholar
Kissileff HR, Carretta JC, Geliebter A, Pi-Sunyer FX: Cholecystokinin and stomach distension combine to reduce food intake in humans. The American Journal of Physiology. 2003, 285 (5): R992-R998.
CAS
Google Scholar
Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA: Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. The Journal of Clinical Investigation. 1985, 75 (4): 1144-1152. 10.1172/JCI111809.
PubMed Central
CAS
PubMed
Google Scholar
Schick RR, Schusdziarra V, Yaksh TL, Go VLW: Brain regions where cholecystokinin exerts its effect on satiety. Annals of the New York Academy of Sciences. 1994, 713: 242-254. 10.1111/j.1749-6632.1994.tb44072.x.
CAS
PubMed
Google Scholar
Crawley JN, Corwin RL: Biological actions of cholecystokinin. Peptides. 1994, 15 (4): 731-755. 10.1016/0196-9781(94)90104-X.
CAS
PubMed
Google Scholar
Moran TH: Cholecystokinin and satiety: current perspectives. Nutrition. 2000, 16 (10): 858-865. 10.1016/S0899-9007(00)00419-6.
CAS
PubMed
Google Scholar
Moran TH, Katz LF, Plata-Salaman CR, Schwartz GJ: Disordered food intake and obesity in rats lacking cholecystokinin A receptors. The American Journal of Physiology. 1998, 274 (3): R618-R625.
CAS
PubMed
Google Scholar
Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR: Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology. 1985, 89 (5): 1070-1077.
CAS
PubMed
Google Scholar
Lin HC, Chey WY: Cholecystokinin and peptide YY are released by fat in either proximal or distal small intestine in dogs. Regulatory Peptides. 2003, 114 (2-3): 131-135. 10.1016/S0167-0115(03)00115-0.
CAS
PubMed
Google Scholar
Eberlein GA, Eysselein VE, Schaeffer M: A new molecular form of PYY: structural characterization of human PYY(3–36) and PYY(1–36). Peptides. 1989, 10 (4): 797-803. 10.1016/0196-9781(89)90116-2.
CAS
PubMed
Google Scholar
Adrian TE, Savage AP, Sagor GR: Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology. 1985, 89 (3): 494-499.
CAS
PubMed
Google Scholar
Batterham RL, Cowley MA, Small CJ: Gut hormone
physiologically inhibits food intake. Nature. 2002, 418 (6898): 650-654. 10.1038/nature00887.
CAS
PubMed
Google Scholar
Pittner RA, Moore CX, Bhavsar SP: Effects of PYY[3-36] in rodent models of diabetes and obesity. International Journal of Obesity. 2004, 28 (8): 963-971. 10.1038/sj.ijo.0802696.
CAS
PubMed
Google Scholar
Batterham RL, Heffron H, Kapoor S: Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metabolism. 2006, 4 (3): 223-233. 10.1016/j.cmet.2006.08.001.
CAS
PubMed
Google Scholar
Batterham RL, Cohen MA, Ellis SM: Inhibition of food intake in obese subjects by peptide
. The New England Journal of Medicine. 2003, 349 (10): 941-948. 10.1056/NEJMoa030204.
CAS
PubMed
Google Scholar
Le Roux CW, Batterham RL, Aylwin SJB: Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology. 2006, 147 (1): 3-8. 10.1210/en.2005-0972.
CAS
PubMed
Google Scholar
Näslund E, Grybäck P, Hellström PM: Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. International Journal of Obesity. 1997, 21 (5): 387-392. 10.1038/sj.ijo.0800418.
PubMed
Google Scholar
Bartolomé MA, Borque M, Martinez-Sarmiento J: Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty. Obesity Surgery. 2002, 12 (3): 324-327. 10.1381/096089202321088084.
Google Scholar
Track NS, McLeod RS, Mee AV: Human pancreatic polypeptide: studies of fasting and postprandial plasma concentrations. Canadian Journal of Physiology and Pharmacology. 1980, 58 (12): 1484-1489.
CAS
PubMed
Google Scholar
Larhammar D: Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Regulatory Peptides. 1996, 65 (3): 165-174. 10.1016/0167-0115(96)00110-3.
CAS
PubMed
Google Scholar
Asakawa A, Inui A, Yuzuriha H: Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology. 2003, 124 (5): 1325-1336. 10.1016/S0016-5085(03)00216-6.
CAS
PubMed
Google Scholar
Clark JT, Kalra PS, Crowley WR, Kalra SP: Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology. 1984, 115 (1): 427-429. 10.1210/endo-115-1-427.
CAS
PubMed
Google Scholar
Zipf WB, O'Dorisio TM, Cataland S, Sotos J: Blunted pancreatic polypeptide responses in children with obesity of Prader-Willi syndrome. The Journal of Clinical Endocrinology & Metabolism. 1981, 52 (6): 1264-1266. 10.1210/jcem-52-6-1264.
CAS
Google Scholar
Berntson GG, Zipf WB, O'Dorisio TM, Hoffman JA, Chance RE: Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome. Peptides. 1993, 14 (3): 497-503. 10.1016/0196-9781(93)90138-7.
CAS
PubMed
Google Scholar
Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ: Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions. Digestive Diseases and Sciences. 1989, 34 (9): 1411-1419. 10.1007/BF01538078.
CAS
PubMed
Google Scholar
Cohen MA, Ellis SM, Le Roux CW: Oxyntomodulin suppresses appetite and reduces food intake in humans. The Journal of Clinical Endocrinology & Metabolism. 2003, 88 (10): 4696-4701. 10.1210/jc.2003-030421.
CAS
Google Scholar
Wynne K, Park AJ, Small CJ: Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes. 2005, 54 (8): 2390-2395. 10.2337/diabetes.54.8.2390.
CAS
PubMed
Google Scholar
Mayo KE, Miller LJ, Bataille D: International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacological Reviews. 2003, 55 (1): 167-194. 10.1124/pr.55.1.6.
CAS
PubMed
Google Scholar
Drucker DJ: The biology of incretin hormones. Cell Metabolism. 2006, 3 (3): 153-165. 10.1016/j.cmet.2006.01.004.
CAS
PubMed
Google Scholar
Herrmann C, Göke R, Richter G, Fehmann H-C, Arnold R, Göke B: Glucagon-like peptide-1 and glucose-dependent insulin releasing polypeptide plasma levels in response to nutrients. Digestion. 1995, 56 (2): 117-126. 10.1159/000201231.
CAS
PubMed
Google Scholar
Deacon CF, Nauck MA, Meier J, Hücking K, Holst JJ: Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide. The Journal of Clinical Endocrinology & Metabolism. 2000, 85 (10): 3575-3581. 10.1210/jc.85.10.3575.
CAS
Google Scholar
Kieffer TJ, McIntosh CHS, Pederson RA: Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology. 1995, 136 (8): 3585-3596. 10.1210/en.136.8.3585.
CAS
PubMed
Google Scholar
Nyberg J, Anderson MF, Meister B: Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation. The Journal of Neuroscience. 2005, 25 (7): 1816-1825. 10.1523/JNEUROSCI.4920-04.2005.
CAS
PubMed
Google Scholar
Baura GD, Foster DM, Porte D: Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. The Journal of Clinical Investigation. 1993, 92 (4): 1824-1830. 10.1172/JCI116773.
PubMed Central
CAS
PubMed
Google Scholar
Woods SC, Lotter EC, McKay LD, Porte D: Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature. 1979, 282 (5738): 503-505. 10.1038/282503a0.
CAS
PubMed
Google Scholar
Brüning JC, Gautam D, Burks DJ: Role of brain insulin receptor in control of body weight and reproduction. Science. 2000, 289 (5487): 2122-2125. 10.1126/science.289.5487.2122.
PubMed
Google Scholar
Cheatham B, Kahn CR: Insulin action and the insulin signaling network. Endocrine Reviews. 1995, 16 (2): 117-142.
CAS
PubMed
Google Scholar
Burks DJ, de Mora JF, Schubert M: IRS-2 pathways integrate female reproduction and energy homeostasis. Nature. 2000, 407 (6802): 377-382. 10.1038/35030105.
CAS
PubMed
Google Scholar
Sinha MK, Ohannesian JP, Heiman ML: Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. The Journal of Clinical Investigation. 1996, 97 (5): 1344-1347. 10.1172/JCI118551.
PubMed Central
CAS
PubMed
Google Scholar
Licinio J, Mantzoros C, Negrão AB: Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nature Medicine. 1997, 3 (5): 575-579. 10.1038/nm0597-575.
CAS
PubMed
Google Scholar
Kastin AJ, Pan W: Dynamic regulation of leptin entry into brain by the blood-brain barrier. Regulatory Peptides. 2000, 92 (1–3): 37-43. 10.1016/S0167-0115(00)00147-6.
CAS
PubMed
Google Scholar
Elias CF, Aschkenasi C, Lee C: Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron. 1999, 23 (4): 775-786. 10.1016/S0896-6273(01)80035-0.
CAS
PubMed
Google Scholar
van den Top M, Lee K, Whyment AD, Blanks AM, Spanswick D: Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus. Nature Neuroscience. 2004, 7 (5): 493-494. 10.1038/nn1226.
CAS
PubMed
Google Scholar
Cowley MA, Smart JL, Rubinstein M: Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 2001, 411 (6836): 480-484. 10.1038/35078085.
CAS
PubMed
Google Scholar
Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995, 269 (5223): 546-549. 10.1126/science.7624778.
CAS
PubMed
Google Scholar
Farooqi IS, Wangensteen T, Collins S: Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. The New England Journal of Medicine. 2007, 356 (3): 237-247. 10.1056/NEJMoa063988.
PubMed Central
CAS
PubMed
Google Scholar
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature. 1994, 372 (6505): 425-432. 10.1038/372425a0.
CAS
PubMed
Google Scholar
Weigle DS, Bukowski TR, Foster DC: Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. The Journal of Clinical Investigation. 1995, 96 (4): 2065-2070. 10.1172/JCI118254.
PubMed Central
CAS
PubMed
Google Scholar
Farooqi IS, Matarese G, Lord GM: Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. The Journal of Clinical Investigation. 2002, 110 (8): 1093-1103.
PubMed Central
CAS
PubMed
Google Scholar
Sinha MK, Caro JF: Clinical aspects of leptin. Vitamins & Hormones. 1998, 54: 1-30. 10.1016/S0083-6729(08)60919-X.
CAS
Google Scholar
Tomas E, Tsao T-S, Saha AK: Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proceedings of the National Academy of Sciences of the United States of America. 2002, 99 (25): 16309-16313. 10.1073/pnas.222657499.
PubMed Central
CAS
PubMed
Google Scholar
Shklyaev S, Aslanidi G, Tennant M: Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proceedings of the National Academy of Sciences of the United States of America. 2003, 100 (24): 14217-14222. 10.1073/pnas.2333912100.
PubMed Central
CAS
PubMed
Google Scholar
Combs TP, Pajvani UB, Berg AH: A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology. 2004, 145 (1): 367-383. 10.1210/en.2003-1068.
CAS
PubMed
Google Scholar
Pajvani UB, Hawkins M, Combs TP: Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. The Journal of Biological Chemistry. 2004, 279 (13): 12152-12162. 10.1074/jbc.M311113200.
CAS
PubMed
Google Scholar